Decoding IgG4-Related Diseases: When Mimics Become the Mystery
"Unraveling the complexities of IgG4-related sclerosing cholangitis and chronic sclerosing sialadenitis, and how to distinguish them from cancer and other conditions."
IgG4-related diseases (IgG4-RD) are a group of conditions that can affect various organs in the body. One such manifestation is IgG4-related sclerosing cholangitis (IgG4-SC), which impacts the bile ducts. A particular type, type 3 IgG4-SC, presents with narrowing (strictures) in the bile ducts, and can closely resemble cholangiocarcinoma (CC), a type of bile duct cancer.
Adding to the diagnostic challenge is chronic sclerosing sialadenitis, also known as Küttner tumor (KT). This uncommon, tumor-like lesion typically affects the salivary glands, often appearing as a mass in the neck. Similar to IgG4-SC, KT is now recognized as part of the IgG4-RD spectrum, but it can easily be mistaken for neck malignancies.
This article will discuss a rare case of type 3 IgG4-SC accompanied by KT and lymphadenitis (inflammation of the lymph nodes). This case is unique because it lacked pancreatic involvement, further complicating the initial suspicion of cancer. We'll explore how doctors navigated these complexities to reach the correct diagnosis and treatment.
A Rare Biliary Mimic
IgG4-related sclerosing cholangitis (IgG4-SC), also called IgG4-related cholangitis, is a rare immune-mediated biliary disease. It can resemble cholangiocarcinoma or primary sclerosing cholangitis (PSC), complicating diagnosis. The disease is characterized by cholestasis and diffuse cholangiographic abnormalities, including circular, symmetrical bile-duct wall thickening, and elevated serum IgG4. Histology can show dense infiltration of IgG4-positive plasma cells and extensive fibrosis in the bile-duct wall.
Diagnosis Requires Multiple Evidence Streams
IgG4-SC can cause symptoms similar to PSC and may occur with pancreatitis, particularly type 1 autoimmune pancreatitis. Diagnosis requires an abnormal cholangiogram, elevated serum IgG4, and histologic analysis. These findings must be considered in the context of a differential diagnosis that includes PSC and cholangiocarcinoma. The overlap in presentation makes distinguishing these conditions a central diagnostic challenge.
Recognizing a Systemic Fibroinflammatory Disease
IgG4-related sclerosing cholangitis is recognized as the biliary manifestation of IgG4-related disease, a systemic fibroinflammatory condition. The condition is characterized by mass lesions or strictures and classical histopathological findings in involved organs. IgG4-SC can mimic PSC and cholangiocarcinoma, presenting a diagnostic problem highlighted in both a 2019 review and a February 5, 2026 article. The supplied sources do not identify a specific discovery date or milestone in its history.
The Case: A Diagnostic Puzzle
A 59-year-old woman from Northeast China presented with jaundice and itching for six months. She also had a mass in her right submandibular region, accompanied by minor salivary dysfunction for three months. Notably, she had undergone surgical removal of a similar mass in the left submandibular region a year prior. Crucially, the patient had no history of ulcerative colitis.
- Mimicking Cancer: The combination of bile duct strictures, a neck mass, and elevated CA19-9 strongly suggested cancer.
- Lack of Pancreatic Involvement: The absence of pancreatic lesions, typical in some IgG4-RD cases, made the diagnosis less straightforward.
- Previous Excision: The patient's history of a similar mass removal complicated the interpretation of the current neck mass.
Evidence Across Distinct IgG4-RD Topics
A 2021 case report and literature review on IgG4-related periodontitis reported serum IgG of 23.70 g/L and IgG4 of 2.800 g/L in the case described. Tissue examination showed significant lymphoplasmacytic infiltration, storiform fibrosis, mitotic figures, and 10 scattered IgG4-positive plasma cells per high-power field. A 2024 review focused on salivary-gland manifestations reports glucocorticoids as initial treatment for symptomatic salivary-gland IgG4-related disease, with immunosuppressive drugs considered for refractory cases. Separately, a review of IgG4-related sialadenitis included 43 eligible articles comprising 1,864 patients.
Mimicry Can Delay Correct Diagnosis
A 2026 article on diagnostic pitfalls reports that IgG4-SC can present with clinical, radiological, and laboratory features resembling malignant perihilar cholangiocarcinoma and PSC. The article says this resemblance can lead to misdiagnosis and delayed intervention. These pitfalls arise because IgG4-SC is a biliary manifestation within the broader spectrum of IgG4-related disease.
A Treatable Disease Compared with Progressive PSC
IgG4-SC and PSC are both cholestatic disorders and can be difficult to differentiate. The cited comparison characterizes PSC as an untreatable, progressive fibroinflammatory disease, whereas IgG4-SC can respond to immunosuppression when recognized in time. This difference makes timely distinction clinically important.
Lessons Learned: Diagnostic Strategies
This case highlights the importance of considering IgG4-RD in patients presenting with bile duct strictures, salivary gland masses, or lymphadenitis, even when typical features like pancreatic involvement are absent. A thorough evaluation, including serological testing for IgG4 levels, imaging studies, and tissue biopsy with immunohistochemical staining, is crucial for accurate diagnosis.
Diagnosis and Treatment Depend on Recognition
A 2024 review describes IgG4-SC as a steroid-responsive fibroinflammatory condition found more commonly in older men and strongly associated with autoimmune pancreatitis. It can be difficult to diagnose because it closely mimics hepatobiliary diseases. A 2026 review likewise describes IgG4-SC as steroid-responsive, commonly associated with type I autoimmune pancreatitis, and capable of mimicking PSC or cholangiocarcinoma. That review says diagnosis relies on histology, imaging, serology, other-organ involvement, and response-to-therapy criteria.
Ultrasonography and fine-needle aspiration biopsy (FNAB) can be valuable tools in evaluating salivary gland masses and differentiating KT from other conditions like malignancies. However, it's essential to interpret these findings in the context of the patient's clinical presentation and other diagnostic results.
Distinguishing IgG4-SC from cholangiocarcinoma requires a comprehensive approach, integrating clinical, serological, morphological, and histological features. Newer techniques like intraductal ultrasonography and cholangioscopy can further aid in the differential diagnosis. Early and accurate diagnosis is critical, as IgG4-RD typically responds well to steroid therapy, preventing unnecessary surgical interventions.